Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.

Schenk M, Eichelmann F, Schulze MB, Rudovich N, Pfeiffer AF, di Giuseppe R, Boeing H, Aleksandrova K.

Biomark Med. 2019 Jun 3. doi: 10.2217/bmm-2018-0351. [Epub ahead of print]

PMID:
31157547
2.

Where are sleeves performed? An analysis of inpatient versus outpatient databases in a large state.

Clapp B, Wicker E, Jones R, Schenk M, Swinney I, Dodoo C, Tyroch A.

Surg Obes Relat Dis. 2019 Mar 20. pii: S1550-7289(18)31283-8. doi: 10.1016/j.soard.2019.03.002. [Epub ahead of print]

PMID:
31056409
3.

Development of a Transplantable GFP+ B-Cell Lymphoma Tumor Cell Line From MHC-Defined Miniature Swine: Potential for a Large Animal Tumor Model.

Schenk M, Matar AJ, Hanekamp I, Hawley RJ, Huang CA, Duran-Struuck R.

Front Oncol. 2019 Apr 2;9:209. doi: 10.3389/fonc.2019.00209. eCollection 2019.

4.

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Güntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD; FLOT4-AIO Investigators.

Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.

PMID:
30982686
5.

Yerba mate (Ilex paraguariensis) favors survival and growth of dopaminergic neurons in culture.

Bernardi A, Ballestero P, Schenk M, Ferrario M, Gómez G, Rivero R, Avale E, Taravini I, Gershanik O, Guerrero S, Ferrario JE.

Mov Disord. 2019 Apr 2. doi: 10.1002/mds.27667. [Epub ahead of print] No abstract available.

PMID:
30938849
6.

Experimental evaluation of matching via a commercially available basketball video game.

Schenk MJ, Reed DD.

J Appl Behav Anal. 2019 Mar 15. doi: 10.1002/jaba.551. [Epub ahead of print]

PMID:
30874311
7.

Evaluation of symptoms and symptom combinations in histamine intolerance.

Schnedl WJ, Lackner S, Enko D, Schenk M, Holasek SJ, Mangge H.

Intest Res. 2019 Mar 7. doi: 10.5217/ir.2018.00152. [Epub ahead of print]

8.

Biosimilars sicher und wirksam.

Schenk M.

MMW Fortschr Med. 2019 Feb;161(3):65. doi: 10.1007/s15006-019-0191-7. German. No abstract available.

PMID:
30778959
9.

Impact of adult attention deficit hyperactivity disorder and medication status on sleep/wake behavior and molecular circadian rhythms.

Coogan AN, Schenk M, Palm D, Uzoni A, Grube J, Tsang AH, Kolbe I, McGowan NM, Wandschneider R, Colla M, Oster H, Thome J, Faltraco F.

Neuropsychopharmacology. 2019 Jun;44(7):1198-1206. doi: 10.1038/s41386-019-0327-6. Epub 2019 Feb 6.

PMID:
30758328
10.

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M.

Haematologica. 2019 May;104(5):955-962. doi: 10.3324/haematol.2018.206797. Epub 2018 Dec 4.

11.

HPV-induzierter Leidensweg.

Schenk M.

MMW Fortschr Med. 2018 Nov;160(20):72. doi: 10.1007/s15006-018-1186-5. German. No abstract available.

PMID:
30478547
12.

Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics.

Lallo A, Gulati S, Schenk MW, Khandelwal G, Berglund UW, Pateras IS, Chester CPE, Pham TM, Kalderen C, Frese KK, Gorgoulis VG, Miller C, Blackhall F, Helleday T, Dive C.

Br J Pharmacol. 2019 Feb;176(3):436-450. doi: 10.1111/bph.14542. Epub 2018 Dec 13.

PMID:
30427531
13.

[Pain Therapy Aspects in Tumour Surgery].

Wirz S, Schenk M, Kieselbach K.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Oct;53(10):704-717. doi: 10.1055/s-0043-104600. Epub 2018 Nov 13. Review. German.

PMID:
30423596
14.

Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS).

Wirsching J, Graßmann S, Eichelmann F, Harms LM, Schenk M, Barth E, Berndzen A, Olalekan M, Sarmini L, Zuberer H, Aleksandrova K.

BMC Med Res Methodol. 2018 Nov 6;18(1):122. doi: 10.1186/s12874-018-0583-x.

15.

Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110).

Modest DP, Fischer von Weikersthal L, Decker T, Vehling-Kaiser U, Uhlig J, Schenk M, Freiberg-Richter J, Peuser B, Denzlinger C, Peveling Genannt Reddemann C, Graeven U, Schuch G, Schwaner I, Stahler A, Jung A, Kirchner T, Held S, Stintzing S, Giessen-Jung C, Heinemann V; XELAVIRI/AIO KRK0110 Investigators.

J Clin Oncol. 2019 Jan 1;37(1):22-32. doi: 10.1200/JCO.18.00052. Epub 2018 Nov 2.

PMID:
30388045
16.

Molecular Background of Pi Deficiency-Induced Root Hair Growth in Brassica carinata - A Fasciclin-Like Arabinogalactan Protein Is Involved.

Kirchner TW, Niehaus M, Rössig KL, Lauterbach T, Herde M, Küster H, Schenk MK.

Front Plant Sci. 2018 Sep 19;9:1372. doi: 10.3389/fpls.2018.01372. eCollection 2018.

17.

Development and quality assessment of a turbid carrot-orange juice blend processed by UV-C light assisted by mild heat and addition of Yerba Mate (Ilex paraguariensis) extract.

Ferrario M, Schenk M, García Carrillo M, Guerrero S.

Food Chem. 2018 Dec 15;269:567-576. doi: 10.1016/j.foodchem.2018.06.149. Epub 2018 Jul 7.

PMID:
30100474
18.

Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.

Knödler M, Körfer J, Kunzmann V, Trojan J, Daum S, Schenk M, Kullmann F, Schroll S, Behringer D, Stahl M, Al-Batran SE, Hacker U, Ibach S, Lindhofer H, Lordick F.

Br J Cancer. 2018 Aug;119(3):296-302. doi: 10.1038/s41416-018-0150-6. Epub 2018 Jul 10.

PMID:
29988111
19.

Shape Control for Experimental Continuation.

Neville RM, Groh RMJ, Pirrera A, Schenk M.

Phys Rev Lett. 2018 Jun 22;120(25):254101. doi: 10.1103/PhysRevLett.120.254101.

PMID:
29979051
20.

Automated closed-loop management of body temperature using forced-air blankets: preliminary feasibility study in a porcine model.

Peter J, Klingert K, Klingert W, Thiel K, Königsrainer A, Grasshoff C, Rosenstiel W, Schenk M.

BMC Anesthesiol. 2018 Jul 3;18(1):80. doi: 10.1186/s12871-018-0542-4.

21.

Unraveling the causes of adaptive benefits of synonymous mutations in TEM-1 β-lactamase.

Zwart MP, Schenk MF, Hwang S, Koopmanschap B, de Lange N, van de Pol L, Nga TTT, Szendro IG, Krug J, de Visser JAGM.

Heredity (Edinb). 2018 Nov;121(5):406-421. doi: 10.1038/s41437-018-0104-z. Epub 2018 Jul 2.

22.

The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer.

Lallo A, Frese KK, Morrow CJ, Sloane R, Gulati S, Schenk MW, Trapani F, Simms N, Galvin M, Brown S, Hodgkinson CL, Priest L, Hughes A, Lai Z, Cadogan E, Khandelwal G, Simpson KL, Miller C, Blackhall F, O'Connor MJ, Dive C.

Clin Cancer Res. 2018 Oct 15;24(20):5153-5164. doi: 10.1158/1078-0432.CCR-17-2805. Epub 2018 Jun 25.

PMID:
29941481
23.

Impact of polar body biopsy on embryo morphokinetics-back to the roots in preimplantation genetic testing?

Schenk M, Groselj-Strele A, Eberhard K, Feldmeier E, Kastelic D, Cerk S, Weiss G.

J Assist Reprod Genet. 2018 Aug;35(8):1521-1528. doi: 10.1007/s10815-018-1207-4. Epub 2018 May 22.

24.

Overwintering temperature and body condition shift emergence dates of spring-emerging solitary bees.

Schenk M, Mitesser O, Hovestadt T, Holzschuh A.

PeerJ. 2018 May 16;6:e4721. doi: 10.7717/peerj.4721. eCollection 2018.

25.

Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network.

Keegan C, Krutzik S, Schenk M, Scumpia PO, Lu J, Pang YLJ, Russell BS, Lim KS, Shell S, Prestwich E, Su D, Elashoff D, Hershberg RM, Bloom BR, Belisle JT, Fortune S, Dedon PC, Pellegrini M, Modlin RL.

J Immunol. 2018 May 1;200(9):3244-3258. doi: 10.4049/jimmunol.1701733. Epub 2018 Apr 2.

26.

Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'.

Haas M, Siveke JT, Schenk M, Lerch MM, Caca K, Freiberg-Richter J, Fischer von Weikersthal L, Kullmann F, Reinacher-Schick A, Fuchs M, Kanzler S, Kunzmann V, Ettrich TJ, Kruger S, Westphalen CB, Held S, Heinemann V, Boeck S.

Eur J Cancer. 2018 May;94:95-103. doi: 10.1016/j.ejca.2018.02.008. Epub 2018 Mar 20.

PMID:
29549862
27.

Fully automated life support: an implementation and feasibility pilot study in healthy pigs.

Klingert W, Peter J, Thiel C, Thiel K, Rosenstiel W, Klingert K, Grasshoff C, Königsrainer A, Schenk M.

Intensive Care Med Exp. 2018 Jan 16;6(1):2. doi: 10.1186/s40635-018-0168-3.

28.

Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material.

Gress TM, Lausser L, Schirra LR, Ortmüller L, Diels R, Kong B, Michalski CW, Hackert T, Strobel O, Giese NA, Schenk M, Lawlor RT, Scarpa A, Kestler HA, Buchholz M.

Oncotarget. 2017 Nov 21;8(64):108223-108237. doi: 10.18632/oncotarget.22601. eCollection 2017 Dec 8.

29.

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.

Sadozai H, Gruber T, Hunger RE, Schenk M.

Front Immunol. 2017 Dec 8;8:1617. doi: 10.3389/fimmu.2017.01617. eCollection 2017. Review.

30.

Non-celiac gluten sensitivity: people without celiac disease avoiding gluten-is it due to histamine intolerance?

Schnedl WJ, Lackner S, Enko D, Schenk M, Mangge H, Holasek SJ.

Inflamm Res. 2018 Apr;67(4):279-284. doi: 10.1007/s00011-017-1117-4. Epub 2017 Nov 27. Review.

PMID:
29181545
31.

Targeting DNA damage in SCLC.

Foy V, Schenk MW, Baker K, Gomes F, Lallo A, Frese KK, Forster M, Dive C, Blackhall F.

Lung Cancer. 2017 Dec;114:12-22. doi: 10.1016/j.lungcan.2017.10.006. Epub 2017 Oct 16. Review.

PMID:
29173760
32.

A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.

Holbrook LM, Sandhar GK, Sasikumar P, Schenk MP, Stainer AR, Sahli KA, Flora GD, Bicknell AB, Gibbins JM.

J Thromb Haemost. 2018 Feb;16(2):367-377. doi: 10.1111/jth.13878. Epub 2018 Jan 15.

33.

β-thalassemia minor, carbohydrate malabsorption and histamine intolerance.

Schnedl WJ, Schenk M, Lackner S, Holasek SJ, Mangge H.

J Community Hosp Intern Med Perspect. 2017 Sep 19;7(4):227-229. doi: 10.1080/20009666.2017.1369378. eCollection 2017 Oct.

34.

Pathophysiological central nervous system changes in a porcine model of acetaminophen-induced acute liver failure.

Thiel C, Lauber J, Klingert W, Klingert K, Morgalla MH, Beschorner R, Peter A, Grasshoff C, Königsrainer A, Schenk M, Thiel K.

Toxicol Lett. 2017 Nov 5;281:119-126. doi: 10.1016/j.toxlet.2017.09.018. Epub 2017 Sep 27.

PMID:
28958773
35.

Efficient generation of mutations mediated by CRISPR/Cas9 in the hairy root transformation system of Brassica carinata.

Kirchner TW, Niehaus M, Debener T, Schenk MK, Herde M.

PLoS One. 2017 Sep 22;12(9):e0185429. doi: 10.1371/journal.pone.0185429. eCollection 2017.

36.

Evaluation of a novel electrosurgical sealing mode in an ex vivo and in vivo porcine model.

Thiel K, Linzenbold W, Enderle MD, Nold B, Königsrainer A, Schenk M, Thiel C.

Surg Endosc. 2018 Mar;32(3):1456-1463. doi: 10.1007/s00464-017-5832-2. Epub 2017 Sep 18.

PMID:
28924734
37.

Circulating tumor cells and CDX models as a tool for preclinical drug development.

Lallo A, Schenk MW, Frese KK, Blackhall F, Dive C.

Transl Lung Cancer Res. 2017 Aug;6(4):397-408. doi: 10.21037/tlcr.2017.08.01. Review.

38.

Algorithm-based arterial blood sampling recognition increasing safety in point-of-care diagnostics.

Peter J, Klingert W, Klingert K, Thiel K, Wulff D, Königsrainer A, Rosenstiel W, Schenk M.

World J Crit Care Med. 2017 Aug 4;6(3):172-178. doi: 10.5492/wjccm.v6.i3.172. eCollection 2017 Aug 4.

39.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J.

Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14.

40.

Kardiovaskuläre Risiken senken.

Schenk M.

MMW Fortschr Med. 2017 Aug;159(14):74. doi: 10.1007/s15006-017-9970-1. German. No abstract available.

PMID:
28803275
41.

An ABC Transporter Is Involved in the Silicon-Induced Formation of Casparian Bands in the Exodermis of Rice.

Hinrichs M, Fleck AT, Biedermann E, Ngo NS, Schreiber L, Schenk MK.

Front Plant Sci. 2017 Apr 28;8:671. doi: 10.3389/fpls.2017.00671. eCollection 2017.

42.

Desynchronizations in bee-plant interactions cause severe fitness losses in solitary bees.

Schenk M, Krauss J, Holzschuh A.

J Anim Ecol. 2018 Jan;87(1):139-149. doi: 10.1111/1365-2656.12694. Epub 2017 Jun 22.

PMID:
28502082
43.

Benign pancreatic hyperenzymemia (Gullo syndrome), histamine intolerance, and carbohydrate malabsorption.

Schnedl WJ, Enko D, Mangge H, Schenk M, Lackner S, Holasek SJ.

Proc (Bayl Univ Med Cent). 2017 Apr;30(2):177-178.

44.

[Mechanisms of chronification in tumor pain?]

Wirz S, Schenk M, Hofbauer H, Kieselbach K.

MMW Fortschr Med. 2017 Mar;159(Suppl 1):78-81. doi: 10.1007/s15006-017-9437-4. Review. German. No abstract available.

PMID:
28357731
45.

Anti-Mullerian hormone concentrations in individual follicular fluids within one stimulated IVF cycle resemble blood serum values.

Schenk M, Kröpfl JM, Obermayer-Pietsch B, Feldmeier E, Weiss G.

J Assist Reprod Genet. 2017 Sep;34(9):1115-1120. doi: 10.1007/s10815-017-0908-4. Epub 2017 Mar 21.

46.

Porcine model characterizing various parameters assessing the outcome after acetaminophen intoxication induced acute liver failure.

Thiel K, Klingert W, Klingert K, Morgalla MH, Schuhmann MU, Leckie P, Sharifi Y, Davies NA, Jalan R, Peter A, Grasshoff C, Königsrainer A, Schenk M, Thiel C.

World J Gastroenterol. 2017 Mar 7;23(9):1576-1585. doi: 10.3748/wjg.v23.i9.1576.

47.

[Use of methadone for support of oncological treatment? : Statement of the working group on tumor pain of the German Pain Society].

Hofbauer H, Schenk M, Kieselbach K, Wirz S.

Schmerz. 2017 Feb;31(1):2-4. doi: 10.1007/s00482-016-0183-9. German. No abstract available.

PMID:
28044195
48.

Biobanking of different body fluids within the frame of IVF-a standard operating procedure to improve reproductive biology research.

Schenk M, Huppertz B, Obermayer-Pietsch B, Kastelic D, Hörmann-Kröpfl M, Weiss G.

J Assist Reprod Genet. 2017 Feb;34(2):283-290. doi: 10.1007/s10815-016-0847-5. Epub 2016 Nov 26.

49.

[Mechanisms of chronification and potential addiction in tumor pain : Comparison with non-tumor pain - A review of the literature].

Wirz S, Schenk M, Kleinmann B, Kieseritzky K.

Schmerz. 2016 Dec;30(6):510-518. Review. German.

PMID:
27832374
50.

[Unclear liver lesions in a 19-year-old woman with acute myeloid leukemia].

Braun B, Karl AP, Dierkes C, Schenk M, Braess J.

Internist (Berl). 2016 Nov;57(11):1121-1125. German.

PMID:
27411791

Supplemental Content

Loading ...
Support Center